Why did biotech stocks fall today?

I don’t have today's market data in front of me unless you share a date or specific tickers. But biotech stocks can fall for a few common reasons. Here are the typical catalysts you might look for:

- Macro factors: Overall market pullback, rising interest rates, or a shift in risk sentiment can hit speculative growth names like biotech hard.
- Clinical trial/news catalysts: Negative trial results, failure to meet primary endpoints, safety concerns, or delays in regulatory timelines (FDA/EMA rulings or PDUFA dates) can drive declines.
- Regulatory and pricing news: Unfavorable regulatory decisions, manufacturing issues, or unfavorable payer/pricing developments.
- Financing concerns: News of secondary offerings, debt issuance, or other dilutive financing can weigh on stock prices.
- Company-specific events: Earnings misses, guidance cuts, management changes, or strategic disappointments.
- Sector rotation: Investors moving money into larger pharma names, commodities, or more defensive sectors can drag the biotech group even if a few companies perform OK.

If you share the date or the tickers you’re watching, I can summarize the day’s likely catalysts and explain why those stocks moved.